Luca Benatti's Net Worth
$426 Thousand
Who is Luca Benatti?
Luca Benatti does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include INTERCEPT PHARMACEUTICALS, INC., and Quince Therapeutics, Inc..
SEC CIK
Luca Benatti's CIK is 0001613842
Past Insider Trading and Trends
2014 was Luca Benatti's most active year for acquiring shares with 3 total transactions. Luca Benatti's most active month to acquire stocks was the month of April. 2023 was Luca Benatti's most active year for disposing of shares, totalling 12 transactions. Luca Benatti's most active month to dispose stocks was the month of October. 2014 saw Luca Benatti paying a total of $111,888.00 for 1,803 shares, this is the most they've acquired in one year. In 2023 Luca Benatti cashed out on 84,847 shares for a total of $638,362.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
INTERCEPT PHARMACEUTICALS, INC. (ICPT) No price found
InvestorLuca Benatti used to own units in Common Stock but no longer holds any shares there. From 2014 to 2023 Luca Benatti acquired a total of 33,558 shares in INTERCEPT PHARMACEUTICALS, INC. at a cost of $212,088.00, Luca also disposed a total of 33,598 shares of INTERCEPT PHARMACEUTICALS, INC. equalling to $638,362.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -33.60K |
$19.00 | -$638,362.00 |
0
|
Nov 8
| |||
Form 4
| +31.82% | 8.11K |
—
|
—
| 33.6K |
May 24
| |||
Form 4
| +43.59% | 7.74K |
—
|
—
| 25.49K |
May 25
| |||
Form 4
| +65.56% | 7.03K |
—
|
—
| 17.75K |
May 27
| |||
Form 4
| +17.48% | 1.59K |
—
|
—
| 10.72K |
May 28
| |||
Form 4
| +20.78% | 1.57K |
—
|
—
| 9.13K |
Jun 20
| |||
Form 4
| +18.88% | 1.2K |
$83.50 | $100,200.00 | 7.56K |
May 14
| |||
Form 4
| +39.11% | 1.79K |
—
|
—
| 6.36K |
Jun 20
| |||
Form 4
| +45.23% | 1.42K |
—
|
—
| 4.57K |
Jun 27
| |||
Form 4
| +62.00% | 1.2K |
—
|
—
| 3.15K |
Jul 19
| |||
Form 4
| +50.31% | 650 |
—
|
—
| 1.94K |
Nov 24
| |||
Form 4
| +162.60% | 800 |
$139.86 | $111,888.00 | 1.29K |
Dec 15
| |||
Form 4
| +1,130.00% | 452 |
—
|
—
| 492 |
Jul 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Quince Therapeutics, Inc. (QNCX) Snapshot price: $0.71
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||